Leanne

Education and Training

Training the Next Generation of Cancer Immunotherapy Experts

The Riddell Centre for Cancer Immunotherapy, a centre of research excellence at the Arnie Charbonneau Cancer Institute, is committed to training the next generation of scientists in the evolving field of cancer immunotherapy. Our training environment provides hands-on experience in cutting-edge research, alongside weekly research rounds, monthly journal clubs, and regular invited speakers. Trainees also benefit from an annual research retreat, dedicated funding opportunities, the ability to participate in a patient-trainee co-mentorship program, and opportunities to engage with the broader community through outreach and events.   

Whether you're an undergraduate student, graduate student, postdoctoral fellow, or a clinical fellow, the Riddell Centre offers a dynamic, interdisciplinary environment where knowledge is shared, ideas are nurtured, and the next generation of cancer immunotherapy leaders are developed.

Riddell Centre

Research Rounds

The Riddell Centre hosts weekly research rounds to foster knowledge exchange, critical thinking and collaboration. Held in-person at Foothills Campus with a virtual attendance option, these sessions provide a unique forum for discussing the latest advancement in cancer immunotherapy.

Mansour

Funding Opportunities

The Riddell Centre is committed to attracting and supporting outstanding trainees. The Centre does this in part by offering funding opportunities targeted towards trainees at all educational stages, fostering their development and success.

Co-Mentorship

Co-Mentorship Program

The Riddell Centre’s Patient-Trainee Co-Mentorship Program fosters meaningful connections between cancer researchers and patients. This initiative provides trainees with firsthand insight into the patient experience, while patients gain a deeper understanding of the research shaping future treatments. Through this unique exchange, the program enhances research relevance, communication skills, and patient-centered innovation.